Genetic analysis of meningococci carried by children and young adults

被引:158
作者
Claus, H
Maiden, MCJ
Wilson, DJ
McCarthy, ND
Jolley, KA
Urwin, R
Hessler, F
Frosch, M
Vogel, U
机构
[1] Univ Oxford, Dept Zool, Oxford OX1 3SY, England
[2] Univ Oxford, Dept Stat, Oxford OX1 3SY, England
[3] Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany
关键词
D O I
10.1086/428590
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Neisseria meningitidis is a diverse commensal bacterium that occasionally causes severe invasive disease. The relationship between meningococcal genotype and capsular polysaccharide, the principal virulence factor and vaccine component, was investigated in carried meningococci isolated from 8000 children and young adults in Bavaria, Germany. Methods. Of the 830 meningococci isolated (carriage rate, 10.4%) by microbiological techniques, 822 were characterized by serogrouping, multilocus sequence typing, and genetic analysis of the capsule region. Statistical and population genetic analyses were applied to these data. Results. The rapid increase in carriage rates with age of carrier, the low prevalence of hyperinvasive meningococci, and the relative prevalence of the 4 disease-associated serogroups were consistent with earlier observations. There was no genetic structuring of the meningococcal population by age of carrier or sampling location; however, there was significant geographic structuring of the meningococci isolated in civil, but not military, institutions. The rate of capsule gene expression did not vary with age of carrier or meningococcal genotype, except for serogroup C, for which increased expression was associated with ST-11 (formerly ET-37) complex meningococci. Conclusions. Serogroup C capsule expression during carriage may contribute to the invasive character of ST-11 complex meningococci and to the high efficacy of meningococcal serogroup C conjugate polysaccharide vaccine.
引用
收藏
页码:1263 / 1271
页数:9
相关论文
共 52 条
[1]   EFFECT OF OUTER-MEMBRANE VESICLE VACCINE AGAINST GROUP-B MENINGOCOCCAL DISEASE IN NORWAY [J].
BJUNE, G ;
HOIBY, EA ;
GRONNESBY, JK ;
ARNESEN, O ;
HOLSTFREDRIKSEN, J ;
HALSTENSEN, A ;
HOLTEN, E ;
LINDBAK, AK ;
NOKLEBY, H ;
ROSENQVIST, E ;
SOLBERG, LK ;
CLOSS, O ;
ENG, J ;
FROHOLM, LO ;
LYSTAD, A ;
BAKKETEIG, LS ;
HAREIDE, B .
LANCET, 1991, 338 (8775) :1093-1096
[2]   Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: Reevaluation of correlates of protection [J].
Borrow, R ;
Andrews, N ;
Goldblatt, D ;
Miller, E .
INFECTION AND IMMUNITY, 2001, 69 (03) :1568-1573
[3]   THE CARRIER STATE - NEISSERIA-MENINGITIDIS [J].
BROOME, CV .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :25-34
[4]   THE STONEHOUSE SURVEY - NASOPHARYNGEAL CARRIAGE OF MENINGOCOCCI AND NEISSERIA-LACTAMICA [J].
CARTWRIGHT, KAV ;
STUART, JM ;
JONES, DM ;
NOAH, ND .
EPIDEMIOLOGY AND INFECTION, 1987, 99 (03) :591-601
[5]   GENETIC-STRUCTURE OF NEISSERIA-MENINGITIDIS POPULATIONS IN RELATION TO SEROGROUP, SEROTYPE, AND OUTER-MEMBRANE PROTEIN PATTERN [J].
CAUGANT, DA ;
MOCCA, LF ;
FRASCH, CE ;
FROHOLM, LO ;
ZOLLINGER, WD ;
SELANDER, RK .
JOURNAL OF BACTERIOLOGY, 1987, 169 (06) :2781-2792
[6]   CLONAL DIVERSITY OF NEISSERIA-MENINGITIDIS FROM A POPULATION OF ASYMPTOMATIC CARRIERS [J].
CAUGANT, DA ;
KRISTIANSEN, BE ;
FROHOLM, LO ;
BOVRE, K ;
SELANDER, RK .
INFECTION AND IMMUNITY, 1988, 56 (08) :2060-2068
[7]  
CAUGANT DA, 1986, J GEN MICROBIOL, V132, P641
[8]   Population genetics and molecular epidemiology of Neisseria meningitidis [J].
Caugant, DA .
APMIS, 1998, 106 (05) :505-525
[9]   Molecular divergence of the sia locus in different serogroups of Neisseria meningitidis expressing polysialic acid capsules [J].
Claus, H ;
Vogel, U ;
Mühlenhoff, M ;
Gerardy-Schahn, R ;
Frosch, M .
MOLECULAR AND GENERAL GENETICS, 1997, 257 (01) :28-34
[10]   Many carried meningococci lack the genes required for capsule synthesis and transport [J].
Claus, H ;
Maiden, MCJ ;
Maag, R ;
Frosch, M ;
Vogel, U .
MICROBIOLOGY-SGM, 2002, 148 :1813-1819